Comments

Dyne Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Dyne Therapeutics (DYN) operate in?

Dyne Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

DYNNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$12.32

-1.29-9.48%

At close: -

$12.32

0.000.00%

After Hours: 4:00 PM EDT

Q4 2024 Earnings were released on Thu Feb 27th, before the market open

Dyne Therapeutics (DYN) Forecast

News Earnings Dyne Therapeutics (DYN) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Dyne Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:DYN | Benzinga

Explore Dyne Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for DYN.

Open	$13.61
Close	$12.32
Volume / Avg.	2.16M / 1.75M
Day Range	$12.28 - $13.70
52 Wk Range	12.87 - 47.45
Market Cap	$1.39B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	32
Short Interest	11.23%
Days to Cover	7.06

Recent News

Why Is Neuromuscular-Focused Dyne Therapeutics Stock Trading Lower On Friday?

Dyne Therapeutics' DYNE-101 shows promising Phase 1/2 results for myotonic dystrophy type 1, with plans for Accelerated Approval by 2026.

Vandana Singh

Crude Oil Dips Over 4%; SPAR Group Shares Spike Higher

Avi Kapoor

Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Dec 24

Jan

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$13.61
Close	$12.32
Volume / Avg.	2.16M / 1.75M
Day Range	$12.28 - $13.70
52 Wk Range	12.87 - 47.45
Market Cap	$1.39B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	32
Short Interest	11.23%
Days to Cover	7.06

About Dyne Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and a...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Dyne Therapeutics (DYN) stock?

You can purchase shares of Dyne Therapeutics (NASDAQ:DYN) through any online brokerage.

View our list of the best stock brokerages

Who are Dyne Therapeutics (DYN) competitors?

Other companies in Dyne Therapeutics’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), 89bio (NASDAQ:ETNB), Ascentage Pharma Group (NASDAQ:AAPG), Syndax Pharmaceuticals (NASDAQ:SNDX) and Arcutis Biotherapeutics (NASDAQ:ARQT).

What is the forecast, or price target, for Dyne Therapeutics (DYN) stock?

Dyne Therapeutics has a consensus price target of $49.18.

What is the current price for Dyne Therapeutics (DYN)?

The stock price for Dyne Therapeutics (NASDAQ: DYN) is $12.32 last updated March 3, 2025 at 4:00 PM EST.

Does Dyne Therapeutics (DYN) pay a dividend?

There are no upcoming dividends for Dyne Therapeutics.

When is Dyne Therapeutics (NASDAQ:DYN) reporting earnings?

Dyne Therapeutics’s Q1 earnings are confirmed for Thursday, May 1, 2025.

Is Dyne Therapeutics (DYN) going to split?

There is no upcoming split for Dyne Therapeutics.

What sector and industry does Dyne Therapeutics (DYN) operate in?

Dyne Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.